Hematology, Transfusion and Cell Therapy

Is asciminib an effective tyrosine kinase inhibitor for chronic myeloid leukemia patients with tyrosine kinase inhibitor resistance? Musab MA Omar; Majed A Alanazi; Denise E. Jackson;

Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis Selin Küçükyurt; Alihan Kelezoğlu; Tuğrul Elverdi; Deniz Özmen; Muhlis Cem Ar; Ahmet Emre Eşkazan;

Impact of the changes in chronic myeloid leukemia classification proposed by the 2022 World Health Organization: a single-center Brazilian study Estela Gasparotto Emiliano; Gustavo Emmanuel Alves Abrantes Santos; Eliana Cristina Martins Miranda; Gislaine Borba Oliveira Duarte; Guilherme Brasil Duffles Amarante; Carmino Antônio De Souza; Katia Borgia Barbosa Pagnano;